Literature DB >> 3693344

Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system.

H Löw1, C Grebing, A Lindgren, M Tally, I L Sun, F L Crane.   

Abstract

Nonpermeable electron acceptors can be reduced by a transplasma membrane electron transport system in suspensions of intact cells. Here we report that diferric transferrin is reduced by HeLa S3 cells. The reduction is recorded spectrophotometrically as the formation of the ferrous complex of bathophenanthroline disulfonate. Ferric ammonium citrate can also be used as an electron acceptor and the presence of low concentrations of diferric transferrin greatly stimulates the reduction of trivalent iron under these conditions. Likewise very low concentrations of ferricyanide, which does not give rise to a ferrous bathophenanthroline disulfonate complex formation, have a strong stimulatory effect on the complex formation when ferric ammonium citrate is the source of ferric iron. Apotransferrin is a potent inhibitor of the reaction. The inhibition occurs at the concentration necessary for complete occupancy of the transferrin receptors. The inhibition can be demonstrated also when high concentrations of ferricyanide are used as electron acceptor. The possible mechanism behind the reported phenomena is discussed, and it is concluded that the transplasma membrane electron transport system can be involved in the process of cellular iron uptake.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693344     DOI: 10.1007/bf00770036

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  41 in total

1.  The interaction of iron-conalbumin (anion) complexes with chick embryo red blood ccells.

Authors:  S C Williams; R C Woodworth
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

2.  Transferrin binding and iron uptake in mouse hepatocytes.

Authors:  E S Cole; J Glass
Journal:  Biochim Biophys Acta       Date:  1983-02-16

3.  Chelator-mediated iron efflux from reticulocytes.

Authors:  E H Morgan
Journal:  Biochim Biophys Acta       Date:  1983-08-24

4.  The interaction of transferrin with isolated hepatocytes.

Authors:  S P Young; P Aisen
Journal:  Biochim Biophys Acta       Date:  1980-12-01

5.  Competitive advantage of diferric transferrin in delivering iron to reticulocytes.

Authors:  H A Huebers; E Csiba; E Huebers; C A Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Equivalence of the two sites of human transferrin upon reduction with dithionite.

Authors:  D C Harris; P V Haroutunian; S M Gutmann
Journal:  Br J Haematol       Date:  1977-10       Impact factor: 6.998

7.  Effect of adenine nucleotides and pyrophosphate on the exchange of transferrin-bound carbonate.

Authors:  A Egyed
Journal:  Biochim Biophys Acta       Date:  1975-12-05

8.  Thermodynamic binding constants of the zinc-human serum transferrin complex.

Authors:  W R Harris
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

9.  Energetics of the calcium-transporting ATPase.

Authors:  C M Pickart; W P Jencks
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

10.  Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells.

Authors:  R Taetle; J M Honeysett; I Trowbridge
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

View more
  11 in total

Review 1.  Electron and proton transport across the plasma membrane.

Authors:  F L Crane; I L Sun; R Barr; H Löw
Journal:  J Bioenerg Biomembr       Date:  1991-10       Impact factor: 2.945

2.  Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators.

Authors:  F Vaillant; J A Larm; G L McMullen; E J Wolvetang; A Lawen
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

3.  Modification of transplasma membrane oxidoreduction by SV40 transformation of 3T3 cells.

Authors:  H Löw; F L Crane; C Grebing; M Isaksson; A Lindgren; I L Sun
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

4.  Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulatum.

Authors:  M M Timmerman; J P Woods
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Transformation with SV40 virus prevents retinoic acid inhibition of plasma membrane NADH diferric transferrin reductase in rat liver cells.

Authors:  I L Sun; W Toole-Simms; F L Crane; D J Morré; H Löw; J Y Chou
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

6.  Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum.

Authors:  M M Timmerman; J P Woods
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Plasma membrane redox and control of sirtuin.

Authors:  Frederick L Crane; Hans Low
Journal:  Age (Dordr)       Date:  2005-12-10

8.  Requirement for coenzyme Q in plasma membrane electron transport.

Authors:  I L Sun; E E Sun; F L Crane; D J Morré; A Lindgren; H Löw
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Effect of cerium lanthanide on Hela and MCF-7 cancer cell growth in the presence of transferring.

Authors:  A A Palizban; H Sadeghi-Aliabadi; F Abdollahpour
Journal:  Res Pharm Sci       Date:  2010-07

10.  Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain.

Authors:  Rashid Deane; Wei Zheng; Berislav V Zlokovic
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.